- Azithromycin – additional study added to the summary information:
We have found one new study comparing azithromycin with standard care (Rashad et al. Res Sq doi: 10.21203/rs.3.rs-181996/v1).
We have found three new studies comparing hydroxychloroquine with placebo or standard care (Omrani et al. EClinMed doi: 10.1016/j.eclinm.2020.100645, Ader et al. medRxiv doi: 10.1101/2021.01.08.20248149 and Hernandez-Cardenas et al. medRxiv doi: 10.1101/2021.02.01.21250371).
We have found one new study comparing intravenous immunoglobulin with standard care (Raman et al. J Infect Dis doi: 10.1093/infdis/jiab098).
- Ivermectin – additional study (Shah Bukhari et al.) added to the summary information:
We have found two new studies comparing ivermectin with standard care (Mohan et al. Res Sq doi: 10.21203/rs.3.rs-191648/v1 and Shah Bukhari et al. medRxiv doi: 10.1101/2021.02.02.21250840).
Note: The newly identified studies listed above are currently under review and updated recommendations will be included in future versions of the guidelines.